Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115949304 | 11594930 | 4 | F | 20150825 | 20160706 | 20151005 | 20160714 | EXP | GB-ASTRAZENECA-2015SE93815 | ASTRAZENECA | 77.00 | YR | M | Y | 172.00000 | KG | 20160714 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115949304 | 11594930 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | U | 19810 | 40 | MG | QD | ||||||
| 115949304 | 11594930 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 7000 | MG | U | U | 0 | 1400 | MG | QD | ||||
| 115949304 | 11594930 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | Y | U | 0 | 40 | MG | QD | ||||||
| 115949304 | 11594930 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | Y | U | 0 | 20 | MG | QD | ||||||
| 115949304 | 11594930 | 5 | SS | INOTUZUMAB OZOGAMICIN | INOTUZUMAB OZOGAMICIN | 1 | Intravenous (not otherwise specified) | 6 | MG | 0 | 1.5 | MG | QD | ||||||
| 115949304 | 11594930 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 500 | MG | U | U | 0 | 100 | MG | QD | ||||
| 115949304 | 11594930 | 7 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 3600 | MG | U | U | 0 | 720 | MG | QD | ||||
| 115949304 | 11594930 | 8 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 3600 | MG | U | U | 0 | 375 | MG | QD | ||||
| 115949304 | 11594930 | 9 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 10 | MG | U | U | 0 | 2 | MG | QD | ||||
| 115949304 | 11594930 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 3000 | MG | 0 | 300 | MG | QD | ||||||
| 115949304 | 11594930 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 115949304 | 11594930 | 12 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 50 | MG | 0 | 10 | MG | QD | ||||||
| 115949304 | 11594930 | 13 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0 | 125 | UG | QD | ||||||||
| 115949304 | 11594930 | 14 | C | FILGRASTIM | FILGRASTIM | 1 | Subcutaneous | 600 | UG | 0 | 300 | UG | QD | ||||||
| 115949304 | 11594930 | 15 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 500 | MG | 0 | 50 | MG | QD | ||||||
| 115949304 | 11594930 | 16 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 4400 | MG | 0 | 200 | MG | BID | ||||||
| 115949304 | 11594930 | 17 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 115949304 | 11594930 | 18 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | DOSE: 10-20 MG | 0 | ||||||||||
| 115949304 | 11594930 | 19 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 40 | MG | 0 | 8 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115949304 | 11594930 | 1 | Gastrointestinal haemorrhage |
| 115949304 | 11594930 | 2 | Neoplasm malignant |
| 115949304 | 11594930 | 3 | Cardiac disorder |
| 115949304 | 11594930 | 4 | Cardiac disorder |
| 115949304 | 11594930 | 5 | Diffuse large B-cell lymphoma |
| 115949304 | 11594930 | 6 | Neoplasm malignant |
| 115949304 | 11594930 | 7 | Neoplasm malignant |
| 115949304 | 11594930 | 8 | Neoplasm malignant |
| 115949304 | 11594930 | 9 | Neoplasm malignant |
| 115949304 | 11594930 | 10 | Prophylaxis |
| 115949304 | 11594930 | 11 | Aortic valve replacement |
| 115949304 | 11594930 | 12 | Unevaluable event |
| 115949304 | 11594930 | 13 | Atrial fibrillation |
| 115949304 | 11594930 | 14 | White blood cell count |
| 115949304 | 11594930 | 15 | Antifungal prophylaxis |
| 115949304 | 11594930 | 16 | Rheumatoid arthritis |
| 115949304 | 11594930 | 17 | Rheumatoid arthritis |
| 115949304 | 11594930 | 18 | Vomiting |
| 115949304 | 11594930 | 19 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115949304 | 11594930 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115949304 | 11594930 | Blood lactic acid increased | |
| 115949304 | 11594930 | Hyponatraemia | |
| 115949304 | 11594930 | Lower respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115949304 | 11594930 | 1 | 20150826 | 0 | ||
| 115949304 | 11594930 | 2 | 20150820 | 20150820 | 0 | |
| 115949304 | 11594930 | 3 | 20150826 | 0 | ||
| 115949304 | 11594930 | 5 | 20150821 | 20150821 | 0 | |
| 115949304 | 11594930 | 6 | 20150820 | 20150824 | 0 | |
| 115949304 | 11594930 | 7 | 20150820 | 20150820 | 0 | |
| 115949304 | 11594930 | 9 | 20150820 | 20150820 | 0 | |
| 115949304 | 11594930 | 10 | 20150815 | 20150826 | 0 | |
| 115949304 | 11594930 | 11 | 20150826 | 0 | ||
| 115949304 | 11594930 | 12 | 20150820 | 20150820 | 0 | |
| 115949304 | 11594930 | 13 | 20150826 | 0 | ||
| 115949304 | 11594930 | 14 | 20150823 | 20150826 | 0 | |
| 115949304 | 11594930 | 15 | 20150815 | 20150826 | 0 | |
| 115949304 | 11594930 | 16 | 20150814 | 20150826 | 0 | |
| 115949304 | 11594930 | 17 | 201107 | 20150826 | 0 | |
| 115949304 | 11594930 | 18 | 20150820 | 20150826 | 0 | |
| 115949304 | 11594930 | 19 | 20150820 | 20150820 | 0 |